Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS
New Delhi: The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS here on Thursday with Dr M V Padma Srivastava, the chief of Neurosciences Centre at the premier institute,…
Covaxin may be launched in February 2021: ICMR
Bharat Biotech may launch COVAXIN as early as February – months earlier than expected – as last-stage trials begin this month and studies have so far shown it is safe and effective, a…
Bharat Biotech to launch Covaxin in Q2 2021
New Delhi: Bharat Biotech is planning to launch its vaccine for Covid-19 in the second quarter next year if it gets the requisite approvals from the Indian regulatory authorities, a top company…
Bharat biotech’s Covid-19 vaccine Covaxin gets DCGI nod for phase 3 clinical trial
New Delhi: The Drugs Controller General of India (DCGI) on Friday permitted Bharat Biotech to conduct phase 3 clinical trials of its indigenously developed Covid-19 vaccine with certain conditions, officials said. A subject expert committee on Covid-19 at…
Bharat Biotech’s COVAXIN gets DCGI approval for Phase I & II Human Clinical Trials
COVAXIN has been successfully developed by Bharat Biotech, a vaccine for COVID-19 by collaborating with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). The SARS-CoV-2…
No more shortage, Bharat Biotech’s subsidiary Chiron Behring launches an anti-rabies vaccine
Seven months back, Bharat Biotech acquired Chiron Chiron Behring vaccines Pvt. Ltd. from GlaxoSmithKline. While launching anti-rabies vaccine Krishna Ella, CMD, Bharat Biotech International Ltd shared that they fulfilled their…
